CHINA CHEMICAL & PHARMACEUTICAL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 21.95 TWD | -0.45% |
|
+1.39% | -9.86% |
| Sales 2022 | 8.46B 260M | Sales 2023 | 8.57B 264M | Capitalization | 7.24B 223M |
|---|---|---|---|---|---|
| Net income 2022 | 478M 14.72M | Net income 2023 | 322M 9.91M | EV / Sales 2022 | 1.44 x |
| Net Debt 2022 | 2.3B 70.81M | Net Debt 2023 | 2.95B 90.78M | EV / Sales 2023 | 1.19 x |
| P/E ratio 2022 |
20.9
x | P/E ratio 2023 |
22.5
x | Employees | - |
| Yield 2022 |
2.41% | Yield 2023 |
2.05% | Free-Float | 64.32% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -0.45% | ||
| 1 week | +1.39% | ||
| Current month | -3.30% | ||
| 1 month | -3.30% | ||
| 3 months | -6.79% | ||
| 6 months | -4.57% | ||
| Current year | -9.86% |
1 week
21.75
22.20
1 month
21.2023.15
Current year
21.2024.90
1 year
21.2028.00
3 years
19.8536.85
5 years
15.4536.85
10 years
14.6036.85
| Managers | Title | Age | Since |
|---|---|---|---|
Chih Yung Wu
CEO | Chief Executive Officer | - | 20-11-04 |
Yi Chun Huang
DFI | Director of Finance/CFO | - | 14-03-06 |
Hui Lan Hu
ADM | Chief Administrative Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Hung Shou Chen
BRD | Director/Board Member | - | 16-05-26 |
Dha-Jen Chou
BRD | Director/Board Member | - | 21-05-20 |
| Chairman | - | 20-11-04 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 117 M€ | -0.14% | - | |
| 0.00% | 34 M€ | +1.32% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-30 | 21.95 | -0.45% | 380,627 |
| 24-04-29 | 22.05 | +0.92% | 688,098 |
| 24-04-26 | 21.85 | -1.13% | 520,872 |
| 24-04-25 | 22.1 | +1.14% | 772,654 |
| 24-04-24 | 21.85 | +0.23% | 493,554 |
End-of-day quote Taiwan S.E., April 29, 2024
More quotes
CHINA CHEMICAL & PHARMACEUTICAL CO., LTD. is a Taiwan-based company principally engaged in the manufacture and sales of pharmaceuticals. The products of the Company include pharmaceuticals for human, animal drugs, medical devices, daily products and nutritious food products. Pharmaceuticals for human include prescription drugs and patented medicines, among others. Medical equipment includes nursing liquid for contact lens, sphygmomanometers and manmade joints. Animal drugs include feedstuff additives and healthcare products for animals, among others. Daily products include toothpastes, shower liquid, facial masks and mouth rinses, among others. The Company operates businesses in Taiwan and Mainland China.
Sector
Pharmaceuticals
Calendar
2024-05-06
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -9.86% | 200M | |
| +19.27% | 43.18B | |
| +21.95% | 23.23B | |
| +15.11% | 14.6B | |
| +38.36% | 11.5B | |
| -7.99% | 6.79B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +10.21% | 5.31B | |
| -2.27% | 4.81B |
- Stock Market
- Equities
- 1701 Stock
